Concepedia

Pharmacogenomic Reporting

Pharmacogenomic Reporting is a scholarly output in clinical pharmacogenomics that systematically communicates the interpretation, clinical significance, and actionable recommendations derived from an individual’s genetic variants affecting drug response, distinguishing it from broader genetic reporting by its focused application to pharmacotherapy decision-making.

29

Publications

1.5K

Citations

167

Authors

88

Institutions

Publications per year

2017–2026

10

Parents

Publications

29

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

Kelly E. Caudle, Henry M. Dunnenberger, Robert R. Freimuth et al. · Genetics in Medicine · 2016 · 548 citations · Full text

, , +17

Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions

Sulev Reisberg, Kristi Krebs, Maarja Lepamets et al. · Genetics in Medicine · 2018 · 100 citations · Full text

, , +17

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements

Rawan Shekhani, Linda Steinacher, Jesse J. Swen et al. · Clinical Pharmacology & Therapeutics · 2019 · 90 citations · Full text

, , +15

Guidance for Industry: Pharmacogenomic Data Submissions

Biotechnology Law Report · 2004 · 82 citations

, , +12

Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine

Darshan Mehta, Ryley Uber, Taylor Ingle et al. · Drug Discovery Today · 2020 · 58 citations · Full text

, , +16

1–5 of 29

Authors

167

  1. LJ
    Lawrence J. Lesko

    Center for Drug Evaluation and Research, United States

    3 publications · 153 citations

    3

    h-index

  2. RM
    Reedik Mägi

    University of Tartu, Estonia

    2 publications · 122 citations

    2

    h-index

  3. MS
    Marc S. Williams

    Geisinger Health System, United States

    2 publications · 577 citations

    2

    h-index

  4. AJ
    Andrew J. Dorner

    Women's Health Research Institute, Canada

    2 publications · 46 citations

    2

    h-index

  5. FW
    Felix W. Frueh

    Center for Drug Evaluation and Research, United States

    2 publications · 67 citations

    2

    h-index

1–5 of 167

Institutions

88

  1. Center for Drug Evaluation and Research

    Silver Spring, United States

    6 h-index

    9 publications

    297 citations

  2. United States Food and Drug Administration

    Silver Spring, United States

    5 h-index

    21 publications

    948 citations

  3. Karolinska Institutet

    Stockholm, Sweden

    3 h-index

    4 publications

    302 citations

  4. Science for Life Laboratory

    Stockholm, Sweden

    2 h-index

    2 publications

    122 citations

  5. Stanford University

    Stanford, United States

    2 h-index

    4 publications

    1.2K citations

  6. Quretec (Estonia)

    Tartu, Estonia

    2 h-index

    4 publications

    244 citations

  7. National Center for Toxicological Research

    Pine Bluff, United States

    2 h-index

    13 publications

    720 citations

  8. University of Tartu

    Tartu, Estonia

    2 h-index

    15 publications

    954 citations

1–8 of 88

Venues

  1. Pharmacogenomics

    6 publications · 185 citations

    6

    h-index

  2. Genetics in Medicine

    GIM · 3 publications · 697 citations

    3

    h-index

  3. Biotechnology Law Report

    2 publications · 105 citations

    2

    h-index

  4. The Pharmacogenomics Journal

    2 publications · 33 citations

    2

    h-index

  5. Clinical and Translational Science

    CTS · 2 publications · 45 citations

    2

    h-index

1–5